Negative margins and Supply Chain challenges continue to plague healthcare organizations. Broad, non-labor assets (supplies, drugs, and purchased services) may not be fully understood or optimized. Our Non-Labor/Supply Chain professionals can advise and develop customized, operational improvement and tactical expense reduction solutions, including the use of levers such as price reduction, utilization reduction and waste reduction, among others.
At this pivotal time for healthcare Supply Chain, staff burnout/fatigue and under-sourcing has hampered the ability to realize the full potential of many hospital Supply Chain functions. Our experts can help organizations identify, deliver, educate, and coach respective stakeholders to achieve significant financial and operational improvements in all facets of medical supplies, drugs, and purchased services.
Rely on us for help with:
| Supply Chain |
|
Supply Chain Operations Improvement |
| |
|
|
- Identification and implementation of uncovered opportunities, including clinical integration
- Expedited spend diagnostics (price variances to market, etc.)
- Narrow (select categories/contracts) or broad focus (financial target), based on specific needs
|
|
- Identify variances to leading practice in key Supply Chain functions, with an eye toward unique needs in People (roles), Process and Technology.
- Implementation of customized strategies to yield improvements in cost, response time and customer satisfaction.
|
| |
|
|
| Ad-Hoc, Rapid Consultation |
|
Interim Management |
| |
|
|
- Evaluation of key strategies/documents, such as business plans and individual contracts / vendor proposals
- Speaker’s bureau for market education on common Supply Chain topics (e.g., SC Performance Dashboards)
|
|
- Short or longer-term assignments to keep operations moving and identify improvements
- Supply Chain VP, Sourcing and Contracting Managers, and other ancillary leaders (e.g., Value Analysis leader)
|
A&M continues to grow Private Equity Performance Improvement business in Europe
June 26, 2025
David Pérez joins to expand the firm’s commercial due diligence capabilities, deepen healthcare sector expertise and bolster the Nordic footprint.
Impending Medicaid Funding Reductions — Strategic Implications for Health Plans
June 11, 2025
In a recent article, A&M Healthcare Industry Group experts explore key policy changes, market dynamics, stakeholder implications and strategic actions for navigating the evolving landscape surrounding the Affordable Care Act marketplace.
Disruption in the ACA Market – Implications and Strategic Responses
June 11, 2025
In a recent article, A&M Healthcare Industry Group experts explore key policy changes, market dynamics, stakeholder implications and strategic actions for navigating the evolving landscape surrounding the Affordable Care Act marketplace.
Alvarez & Marsal's Healthcare Industry Group Appoints Roger Weems as a Managing Director
June 4, 2025
A&M welcomes Roger Weems as a Managing Director in its Healthcare Industry Group within its Health Systems Practice. Mr. Weems' joining advances their firm's ability to support hospitals and health systems with large scale, operational and financial transformation.
